Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 722 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR Treatment with Encorafenib Plus Cetuximab Plus FOLFIRI Improves Outcomes in Patients with BRAF V600E-mutated mCRC FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors MOST POPULAR Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance... November 7, 2025 Adjuvant Pembrolizumab Plus Chemotherapy Improves DFS in Patients with Newly-Diagnosed, High-Risk... October 1, 2024 Imetelstat Shows Durable Transfusion Independence and Disease-Modifying Activity in Heavily Transfused... December 11, 2023 Promising Results Are Provided by Tebentafusp in Metastatic Uveal Melanoma December 12, 2020 Load more HOT NEWS “Selfless and Incredible” Mother Leaves Behind Five Children After Battling Breast... ΚΑΡΚΙΝΟΣ ΤΡΑΧΗΛΟΥ ΜΗΤΡΑΣ Should People with Cancer and Cancer Survivors Get the Flu Vaccine? Advancing Cancer Prevention: A Conversation with NCI’s Dr. Philip Castle
